Global Veterinary Healthcare Market Size By Type (Medicines, Vaccine), By Application (Companion Animals, Livestock Animals), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Healthcare Market was valued at USD 42.3 billion in 2023 and is projected to surpass USD 74.6 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. The market growth is driven by increasing pet ownership, rising awareness of animal health, growing expenditure on veterinary services, and advancements in animal healthcare technologies. The rising prevalence of zoonotic diseases and livestock-related diseases is also boosting demand for veterinary healthcare products and services worldwide.

Drivers:

1. Rising Pet Ownership and Companion Animal Adoption:

The global increase in pet adoption, especially in urban regions, is significantly driving the demand for veterinary healthcare services. Pet owners are increasingly investing in preventive healthcare, diagnostics, and treatment for their animals.

2. Advancements in Veterinary Technology:

Technological innovations such as telemedicine, wearable devices for animals, advanced diagnostic imaging, and AI-powered veterinary diagnostics are enhancing the capabilities of veterinary healthcare providers.

3. Increasing Livestock Population and Productivity:

Rising demand for meat, dairy, and other animal-based products is driving the need for veterinary healthcare to improve livestock productivity and disease management.

Restraints:

1. High Cost of Veterinary Healthcare:

Advanced veterinary treatments, diagnostics, and surgeries can be expensive, limiting accessibility for certain population segments, particularly in developing countries.

2. Lack of Skilled Veterinary Professionals:

The shortage of trained veterinary professionals in rural and underdeveloped regions may hamper the market growth.

Opportunity:

1. Growth in Tele-veterinary Services:

The increasing adoption of telemedicine in veterinary care offers significant growth opportunities, especially in remote areas where access to veterinary services is limited.

2. Expansion in Emerging Markets:

Emerging economies in Asia-Pacific and Latin America are investing heavily in veterinary infrastructure, providing lucrative opportunities for market players.

Market by System Type Insights:

Based on system type, the Veterinary Pharmaceuticals segment accounted for the largest market share in 2023. The segment includes vaccines, anti-infectives, parasiticides, and anti-inflammatory drugs used for preventive and therapeutic animal healthcare. Veterinary diagnostics is expected to witness the fastest growth due to rising awareness about animal diseases and early detection technologies.

Market by End-use Insights:

Based on end-use, the Companion Animals segment dominated the market in 2023, accounting for over 55% of the market share. The segment’s growth is attributed to rising pet humanization trends and increased spending on pet care. The Livestock segment is also growing steadily due to the need for maintaining healthy herds and ensuring food safety.

Market by Regional Insights:

North America led the global veterinary healthcare market in 2023, driven by high pet ownership rates, advanced healthcare infrastructure, and significant expenditure on animal health. Asia-Pacific is expected to register the highest CAGR during the forecast period due to increasing livestock population, pet adoption, and improving veterinary services in countries like China, India, and Japan.

Competitive Scenario:

Key players operating in the Global Veterinary Healthcare Market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Santé Animale, Virbac, IDEXX Laboratories, Vetoquinol S.A., Dechra Pharmaceuticals, and Bayer Animal Health. These companies are focusing on expanding their product portfolios, investing in R&D, and adopting strategies like partnerships, acquisitions, and regional expansion.

Scope of Work – Global Veterinary Healthcare Market:

Report Metric Details

Market Size (2023) USD 42.3 billion

Projected Market Size (2031) USD 74.6 billion

CAGR (2023-2031) 7.2%

Key Segments by System Type Pharmaceuticals, Diagnostics, Medical Devices

Key Segments by End-Use Companion Animals, Livestock

Leading Region North America

Key Players Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Santé Animale, Virbac, IDEXX Laboratories, Vetoquinol S.A., Dechra Pharmaceuticals, Bayer Animal Health

Key Market Developments:

In 2023, Zoetis Inc. launched a next-generation parasiticide for pets, enhancing its product portfolio in the companion animal segment.

In 2022, Elanco Animal Health expanded its presence in the Asia-Pacific region by acquiring a local veterinary pharmaceutical company.

In 2023, IDEXX Laboratories introduced advanced veterinary diagnostic imaging solutions with AI integration for early disease detection in pets.

In 2024, Boehringer Ingelheim Animal Health partnered with veterinary clinics globally to implement tele-veterinary solutions.

FAQs:

1. What is the current market size of the Global Veterinary Healthcare Market?

The Global Veterinary Healthcare Market was valued at USD 42.3 billion in 2023.

2. What is the major growth driver of the Global Veterinary Healthcare Market?

The major growth driver is the rising pet ownership and increasing expenditure on animal healthcare services.

3. Which is the largest region during the forecast period in the Global Veterinary Healthcare Market?

North America is expected to remain the largest region during the forecast period.

4. Which segment accounted for the largest market share in the Global Veterinary Healthcare Market?

The Pharmaceuticals segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Veterinary Healthcare Market?

Key market players include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Santé Animale, Virbac, IDEXX Laboratories, Vetoquinol S.A., Dechra Pharmaceuticals, and Bayer Animal Health.